Select another study category: Amyotrophic Lateral Sclerosis AnesthesiologyCancer Control/Symptom PreventionCancer, BladderCancer, BrainCancer, BreastCancer, ColorectalCancer, EsophagealCancer, GeneralCancer, GynecologicCancer, Head and NeckCancer, HIV/AIDS MalignancyCancer, LiverCancer, LungCancer, LymphomaCancer, MelanomaCancer, NeuroendocrineCancer, PancreaticCancer, ProstateCancer, RenalCancer, Solid TumorsCardiologyCrohn's DiseaseDiabetes, Type 1Fatty Liver DiseaseHealthy ControlsHepatitisHepatorenal SyndromeLiver Disease RegistryLupusMultiple SclerosisOtherParkinson's DiseasePrimary Biliary CirrhosisPrimary Sclerosing CholangitisRadiologyRelapsing PolychondritisRheumatoid ArthritisSclerodermaSphincter of Oddi DysfunctionStrokeUrology

---

Rheumatoid Arthritis

---

To participate in a BRI clinical trial, please contact the study coordinator listed in each of the study links below, or send an e-mail to the Clinical Research Program. Please click on individual studies for more information.

Studies currently accepting study participants:

• A Double-Blind, Randomized, Parallel-Arm, Multicenter Study to Determine the Dose Response of Methotrexate (MTX) in Combination Therapy with Adalimumab in Subjects with Early Rheumatoid Arthritis (CONCERTO)
• A Multicenter, Double-Blind, Randomized, Parallel-Arm Study to Determine the Effect of Methotrexate Dose on Clinical Outcome and Ultrasonographic Signs in Subjects with Moderately to Severely Active Rheumatoid Arthritis Treated with Adalimumab (MUSICA)

Studies currently not accepting study participants:

• Studies of the Etiology of Rheumatoid Arthritis (SERA)